Debra Knuckles, N.P

NPI: 1679610844
Total Payments
$7,529
2024 Payments
$1,433
Companies
31
Transactions
444
Medicare Patients
2,136
Medicare Billing
$427,591

Payment Breakdown by Category

Food & Beverage$7,487 (99.4%)
Education$42.00 (0.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $7,487 442 99.4%
Education $42.00 2 0.6%

Top Paying Companies

Company Total Records Latest Year
Salix Pharmaceuticals, a division of Bausch Health US, LLC $1,864 98 $0 (2024)
Collegium Pharmaceutical, Inc. $1,132 61 $0 (2024)
ABBVIE INC. $1,048 81 $0 (2024)
Azurity Pharmaceuticals, Inc. $394.93 23 $0 (2024)
PFIZER INC. $329.56 27 $0 (2024)
IDORSIA PHARMACEUTICALS US INC $325.40 20 $0 (2024)
Merck Sharp & Dohme LLC $309.55 18 $0 (2023)
Arbor Pharmaceuticals, Inc. $228.83 12 $0 (2022)
RedHill Biopharma Inc. $193.19 13 $0 (2022)
Biohaven Pharmaceuticals, Inc. $185.12 14 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,433 86 Collegium Pharmaceutical, Inc. ($292.02)
2023 $1,935 114 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($503.06)
2022 $2,151 118 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($762.25)
2021 $2,010 126 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($427.50)

All Payment Transactions

444 individual payment records from CMS Open Payments — Page 1 of 18

Date Company Product Nature Form Amount Type
12/19/2024 Azurity Pharmaceuticals, Inc. HORIZANT (Drug) Food and Beverage In-kind items and services $6.50 General
Category: CEREBROVASCULARCNS
12/17/2024 Collegium Pharmaceutical, Inc. XTAMPZA (Drug) Food and Beverage Cash or cash equivalent $14.15 General
Category: Opioid Analgesic
12/10/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $8.83 General
Category: PAIN
12/04/2024 Azurity Pharmaceuticals, Inc. HORIZANT (Drug) Food and Beverage In-kind items and services $17.45 General
Category: CEREBROVASCULARCNS
12/02/2024 Virtus Pharmaceuticals LLC LEVORPHANOL TARTRATE (Drug) Food and Beverage In-kind items and services $16.62 General
Category: ANALGESICS - OPIOID
11/20/2024 Azurity Pharmaceuticals, Inc. HORIZANT (Drug) Food and Beverage In-kind items and services $18.66 General
Category: CEREBROVASCULARCNS
11/12/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $31.76 General
Category: NEUROSCIENCE
11/07/2024 Azurity Pharmaceuticals, Inc. HORIZANT (Drug) Food and Beverage In-kind items and services $16.49 General
Category: CEREBROVASCULARCNS
11/06/2024 IDORSIA PHARMACEUTICALS US INC QUVIVIQ (Drug) Food and Beverage In-kind items and services $16.45 General
Category: Insomnia
11/04/2024 Collegium Pharmaceutical, Inc. XTAMPZA (Drug) Food and Beverage Cash or cash equivalent $16.17 General
Category: Opioid Analgesic
10/30/2024 VERTEX PHARMACEUTICALS INCORPORATED Food and Beverage In-kind items and services $26.48 General
10/23/2024 Azurity Pharmaceuticals, Inc. HORIZANT (Drug) Food and Beverage In-kind items and services $17.01 General
Category: CEREBROVASCULARCNS
10/23/2024 Azurity Pharmaceuticals, Inc. HORIZANT (Drug) Food and Beverage In-kind items and services $0.55 General
Category: CEREBROVASCULARCNS
10/22/2024 Abbott Laboratories ETERNA (Device) Food and Beverage In-kind items and services $24.83 General
Category: Neuromodulation
10/15/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $5.99 General
Category: NEUROSCIENCE
10/14/2024 Collegium Pharmaceutical, Inc. XTAMPZA (Drug) Food and Beverage Cash or cash equivalent $23.98 General
Category: Opioid Analgesic
10/07/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $23.89 General
Category: PAIN
10/01/2024 Azurity Pharmaceuticals, Inc. HORIZANT (Drug) Food and Beverage In-kind items and services $17.46 General
Category: CEREBROVASCULARCNS
09/30/2024 Collegium Pharmaceutical, Inc. XTAMPZA (Drug) Food and Beverage Cash or cash equivalent $19.90 General
Category: Opioid Analgesic
09/24/2024 SCILEX PHARMACEUTICALS INC. ZTLido (Drug) Food and Beverage In-kind items and services $21.70 General
Category: Analgesic
09/17/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $21.82 General
Category: NEUROSCIENCE
09/16/2024 Azurity Pharmaceuticals, Inc. HORIZANT (Drug) Food and Beverage In-kind items and services $20.75 General
Category: CEREBROVASCULARCNS
09/11/2024 IDORSIA PHARMACEUTICALS US INC QUVIVIQ (Drug) Food and Beverage In-kind items and services $13.75 General
Category: Insomnia
09/10/2024 Collegium Pharmaceutical, Inc. XTAMPZA (Drug) Food and Beverage Cash or cash equivalent $23.98 General
Category: Opioid Analgesic
09/09/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $34.44 General
Category: NEUROSCIENCE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 13 870 4,209 $600,600 $206,404
2022 8 534 2,665 $254,899 $77,623
2021 12 524 1,830 $256,468 $92,825
2020 6 208 805 $145,381 $50,740
Total Patients
2,136
Total Services
9,509
Medicare Billing
$427,591
Procedure Codes
39

All Medicare Procedures & Services

39 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms Office 2023 112 398 $186,250 $77,518 41.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 150 910 $187,460 $68,601 36.6%
80307 Testing for presence of drug, by chemistry analyzers Office 2023 136 633 $126,600 $38,080 30.1%
20553 Injection of trigger points, 3 or more muscles Office 2023 29 130 $15,600 $4,323 27.7%
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms Office 2023 16 32 $10,800 $4,320 40.0%
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms Office 2023 24 30 $8,400 $3,252 38.7%
90791 Psychiatric diagnostic evaluation Office 2023 27 27 $5,400 $3,076 57.0%
96127 Assessment of emotional or behavioral problems Office 2023 151 875 $21,875 $2,718 12.4%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 18 18 $7,200 $1,630 22.6%
96160 Administration and interpretation of patient-focused health risk assessment Office 2023 151 874 $21,850 $1,347 6.2%
20610 Aspiration and/or injection of fluid from large joint Office 2023 11 23 $3,250 $947.82 29.2%
J1040 Injection, methylprednisolone acetate, 80 mg Office 2023 18 58 $2,900 $511.77 17.6%
J1885 Injection, ketorolac tromethamine, per 15 mg Office 2023 27 201 $3,015 $77.75 2.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 126 860 $177,129 $63,672 35.9%
20553 Injection of trigger points, 3 or more muscles Office 2022 36 149 $17,880 $5,474 30.6%
80305 Testing for presence of drug, read by direct observation Office 2022 93 355 $24,850 $4,279 17.2%
96127 Assessment of emotional or behavioral problems Office 2022 113 584 $14,600 $1,967 13.5%
20610 Aspiration and/or injection of fluid from large joint Office 2022 16 26 $3,500 $1,058 30.2%
96160 Administration and interpretation of patient-focused health risk assessment Office 2022 113 584 $14,600 $971.04 6.7%
J1040 Injection, methylprednisolone acetate, 80 mg Office 2022 12 21 $1,050 $163.73 15.6%
J1885 Injection, ketorolac tromethamine, per 15 mg Office 2022 25 86 $1,290 $38.43 3.0%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 117 998 $205,588 $80,440 39.1%
20553 Injections of trigger points in 3 or more muscles Office 2021 33 99 $11,880 $3,742 31.5%
80305 Testing for presence of drug, read by direct observation Office 2021 95 226 $15,820 $2,835 17.9%
99205 New patient outpatient visit, total time 60-74 minutes Office 2021 12 12 $4,800 $1,535 32.0%

About Debra Knuckles, N.P

Debra Knuckles, N.P is a Family healthcare provider based in Concord, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2007. The National Provider Identifier (NPI) number assigned to this provider is 1679610844.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Debra Knuckles, N.P has received a total of $7,529 in payments from pharmaceutical and medical device companies, with $1,433 received in 2024. These payments were reported across 444 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($7,487).

As a Medicare-enrolled provider, Knuckles has provided services to 2,136 Medicare beneficiaries, totaling 9,509 services with total Medicare billing of $427,591. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.

Practice Information

  • Specialty Family
  • Other Specialties Nurse Practitioner
  • Location Concord, NC
  • Active Since 01/30/2007
  • Last Updated 08/13/2015
  • Taxonomy Code 363LF0000X
  • Entity Type Individual
  • NPI Number 1679610844

Products in Payments

  • RELISTOR (Drug) $1,864
  • XTAMPZA (Drug) $988.62
  • UBRELVY (Drug) $788.68
  • NURTEC ODT (Drug) $591.51
  • Horizant (Drug) $367.58
  • QUVIVIQ (Drug) $325.40
  • BELSOMRA (Drug) $309.55
  • QULIPTA (Drug) $259.23
  • HORIZANT (Drug) $256.18
  • Movantik (Drug) $193.19
  • ZTLido (Drug) $165.85
  • Kloxxado (Drug) $156.52
  • Belbuca (Drug) $143.50
  • Lucemyra (Drug) $139.92
  • Saxenda (Drug) $97.76
  • Dayvigo (Drug) $97.25
  • PROLATE (Drug) $88.38
  • COMIRNATY (Biological) $77.99
  • Proclaim IPG (Device) $64.97
  • BELBUCA (Drug) $61.18

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Doctors in Concord